


Food Beverages & Tobacco | Small Cap
Nath Bio-Genes demonstrates a mixed financial performance. Its solvency position is strong, indicating a stable financial structure. Growth metrics are promising, driven by operating profit and asset expansion. However, liquidity is a concern, with very low ratios suggesting potential difficulties in meeting short-term obligations. Financial ratios are also weak, reflecting low earnings and book value per share, although capital expenditure management is effective. Profitability is varied, with a strong return on capital employed contrasting with low margins and returns on equity and assets. While the company shows potential for growth and maintains a solid equity base, addressing liquidity and profitability challenges is crucial for sustained financial health. The company's reliance on specific operational efficiencies and asset growth highlights the need for diversified strategies to ensure long-term stability and competitiveness in the FMCG sector.
Nath Bio-Genes demonstrates a mixed financial performance. Its solvency position is strong, indicating a stable financial structure. Growth metrics are promising, driven by operating profit and asset expansion. However, liquidity is a concern, with very low ratios suggesting potential difficulties in meeting short-term obligations. Financial ratios are also weak, reflecting low earnings and book value per share, although capital expenditure management is effective. Profitability is varied, with a strong return on capital employed contrasting with low margins and returns on equity and assets. While the company shows potential for growth and maintains a solid equity base, addressing liquidity and profitability challenges is crucial for sustained financial health. The company's reliance on specific operational efficiencies and asset growth highlights the need for diversified strategies to ensure long-term stability and competitiveness in the FMCG sector.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
7.06
Industry Median
15.86
Small Cap Median
15.86
P/E RATIO
7.53
P/B RATIO
0.46
Industry Median
1.82
Small Cap Median
1.82
P/S RATIO
0.73
Industry Median
1.15
Small Cap Median
1.15
Others
PEG RATIO
0.00
EV/EBITDA RATIO
4.01
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹164.98 as on Jul 13, 2026.
The company's growth metrics present a mixed picture. While operating profit and asset growth show positive momentum, revenue and net income growth are stagnant, and earnings per share growth is negative. This suggests operational improvements and asset expansion have not yet translated into overall revenue gains. Addressing revenue generation and EPS decline is crucial for sustainable growth. On the positive side, asset growth indicates potential for future expansion and increased market presence.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 1.74 | 5.98 | 8.06 | 66.04 | |
| Operating Profit Growth Rate | 32.43 | 2.04 | 2 | 1.96 | |
| Earnings Per Share (EPS) Growth | -151.97 | 13.13 | -2.59 | 7.88 | |
| Asset Growth Rate | 7.31 | 10.97 | 16.59 | 6.92 | |
| Net Income Growth Rate | -152.24 | 14.29 | -2.5 | 7.69 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jeyyam Global Foods Ltd | 8.14 | 7.77 | Neutral | 30.00 | 2.89 | 14.00 |
| 2 | Sheetal Universal Ltd | 7.88 | 29.35 | Neutral | 21.00 | 10.05 | 12.00 |
| 3 | Upsurge Seeds of Agriculture Ltd | 7.34 | 14.01 | Neutral | 14.00 | 7.42 | 7.00 |
| 4 | Shreeoswal Seeds & Chemicals Ltd | 6.94 | 33.38 | Overvalued | 15.00 | 0.32 | 7.00 |
| 5 | Sukhjit Starch & Chemicals Ltd | 6.56 | 19.58 | Neutral | 83.00 | 8.35 | 27.00 |
| 6 | Indo US Bio-Tech Ltd | 5.37 | 32.39 | Highly Overvalued | 6.79 | 6.55 | 5.06 |
| 7 | Nath Bio-Genes (India) Ltd | 4.76 | 7.53 | Neutral | 52.00 | 23.38 | 42.00 |
| 8 | TBI Corn Ltd | 4.72 | 6.05 | Neutral | 35.00 | 10.11 | 19.00 |
| 9 | KCK Industries Ltd | 4.67 | 207.27 | Neutral | 0.02 | 0.07 | 0.42 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT